LSUHSC COBRE:PROJ 3: ALTERNATIONS IN T CELL SIGNAL TRANSDUCTION
LSUHSC COBRE:PROJ 3: ALTERNATIONS IN T CELL SIGNAL TRANSDUCTION
批准号:
7610787
负责人:
DIEGO H AVILES
金额:
$14.32万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-01 至 2008-06-30
关键词:
ApoptosisBindingCellsChildChronicComplexComputer Retrieval of Information on Scientific Projects DatabaseDataEnd stage renal failureFrequenciesFundingFutureGlucocorticoid ReceptorGrantInflammationInstitutionInterleukin-2LeadLiquid substanceMethodologyMolecularNF-kappa BNephrotic SyndromeNitrogenNuclearNuclear TranslocationPathogenesisPatientsPolymerase Chain ReactionProcessProductionResearchResearch Ethics CommitteesResearch PersonnelResourcesRoleSTAT5A geneSamplingSignal TransductionSourceSteroid ResistanceSteroid-resistant idiopathic nephrotic syndromeSteroidsT-LymphocyteTestingTimeUnited States National Institutes of HealthWorkbasein vitro Modelnuclear transferp65prevent
中文摘要
这个子项目是许多研究子项目中利用
资源由NIH/NCRR资助的中心拨款提供。子项目和
调查员(PI)可能从NIH的另一个来源获得了主要资金,
并因此可以在其他清晰的条目中表示。列出的机构是
该中心不一定是调查人员的机构。
慢性炎症引起的SRNS患者T细胞信号转导的改变:
A.具体目标
激素抵抗型特发性肾病综合征(SRINS)是儿童终末期肾病的主要原因。有强有力的证据支持T细胞在SRINS和激素敏感型特发性肾病综合征(SSINS)的发病机制中的作用。申请者的初步研究表明,SRINS患者的T细胞IL-2表达增加,而NF-kB p65表达选择性降低。这是相关的,因为核因子-kB p65的表达减少可以减少T细胞的凋亡,增加IL-2的产生,从而激活STAT5。反过来,STAT5可以与糖皮质激素受体(GCR)结合,阻止其核转位,导致类固醇耐药。我们的初步数据支持这一假说,即SRINS患者存在损害GCR核转位并导致类固醇耐药的信号转导机制的特定改变。患者样本和体外模型将被用来完成拟议的工作。为了检验这一假设,我们提出了以下具体目标
1.确定SRINS与SSINS患者T细胞改变的频率。这一具体目标将扩大最初的观察,并确定与SRINS的联系。
2.验证核因子-kB p65缺失与SRINS T细胞GCR核移植受损有关的假设
A.在患者的T细胞中证明这一现象。
B.建立体外模型以检验分子机制。
3.验证SRINS中IL-2活性增加与STAT-5产生增加和GCR-STAT-5复合体形成增加有关的假设。
B.研究和成果
这些将根据具体目标进行讨论。
1.确定SRINS与SSINS患者T细胞改变的频率。申请人已获得IRB批准,并开始收集患者样本。另外六个中心正在获得IRB的批准。实时聚合酶链式反应的方法已经过验证,可以使用的是所建议的引物和可用于所建议的实验的有限数量的细胞。到目前为止收集的样本已保存在液氮中,以供将来分析。将使用负选择列隔离T细胞。
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Alterations in T cell signal transduction caused by chronic inflammation in SRNS:
A. Specific Aims
Steroid-resistant idiopathic nephrotic syndrome (SRINS) is a primary cause for end stage renal disease in children. There is strong evidence supporting the role of T cells in the pathogenesis of SRINS and steroid sensitive idiopathic nephrotic syndrome (SSINS). The applicant preliminary studies have shown that T cells from SRINS patients have an increased expression of IL-2 and a selective decrease in NF-kB p65. This is relevant since decreased expression of NF-kB p65 can decrease T cell apoptosis an increase IL-2 production, which activates STAT5. In turn, STAT 5 can bind the glucocorticoid receptor (GCR) preventing its nuclear translocation and resulting in steroid resistance. Our preliminary data support the hypothesis that patients with SRINS have specific alterations in signal transduction mechanism that impair nuclear tranlocation of GCR and lead to steroid resistance. Patient samples and in vitro models will be used to accomplish the proposed work. To test the hypothesis, we propose the following specific aims
1. Determine the frequency of alterations in T cells from patients with SRINS vs. SSINS. This specific aim will expand initial observations and determine association with SRINS.
2. To test the hypothesis that the absence of NF-kB p65 is associated with impaired nuclear transfer of of the GCR in T cells from SRINS
a. Demonstrate this phenomenom in T cells from patients.
b. Develop an in vitro model to test molecular mechanism.
3. Test the hypothesis that increased IL-2 activity in SRINS is associated with increased STAT 5 production and increased formation of GCR-STAT 5 complexes.
B. Studies and Results
These will be discussed based on the specific aims
1. Determine the frequency of alterations in T cells from patients with SRINS vs. SSINS. The applicant has obtained IRB approval and started collecting patient samples. Six additional centers are in the process of obtaining IRB approval. Methodologies for real time PCR have been validated for the proposed primers to be used and the limited amount of cells available for the proposed exeriments. The samples collected so far have been saved on liquid nitrogen for future analysis. T cells will be isolated using negative selection columns.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ALTERNATIONS IN T CELL SIGNAL TRANSDUCTION CAUSED BY INFLAMMATION IN SRNS
-
批准号:7959914
-
项目类别:
-
资助金额:$19.88万
-
财政年份:2009
-
负责人:DIEGO H AVILES
-
依托单位:
ALTERNATIONS IN T CELL SIGNAL TRANSDUCTION CAUSED BY INFLAMMATION IN SRNS
-
批准号:7720484
-
项目类别:
-
资助金额:$13.94万
-
财政年份:2008
-
负责人:DIEGO H AVILES
-
依托单位:
Steroid Resistance in Nephrotic Syndrome
-
批准号:7197275
-
项目类别:
-
资助金额:$12.23万
-
财政年份:2006
-
负责人:DIEGO H AVILES
-
依托单位:
Steroid Resistance in Nephrotic Syndrome
-
批准号:6967183
-
项目类别:
-
资助金额:$12.6万
-
财政年份:2006
-
负责人:DIEGO H AVILES
-
依托单位:
LSUHSC COBRE:PROJ 3: T CELL SIGNAL TRANSDUCT*CAUSED BY CHRONIC INFLAMMAT*IN SRNS
-
批准号:7382265
-
项目类别:
-
资助金额:$19.76万
-
财政年份:2006
-
负责人:DIEGO H AVILES
-
依托单位:
LSUHSC COBRE:PROJ 3: T CELL SIGNALING
-
批准号:7171451
-
项目类别:
-
资助金额:$20.13万
-
财政年份:2005
-
负责人:DIEGO H AVILES
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: